Topical fibrin sealant versus intravenous tranexamic acid for reducing blood loss following total knee arthroplasty: A systematic review and meta-analysis

International Journal of Surgery

Volumn 32, Issue , 2016, Pages 31-37

  Gao, Fuqiang ^a   Ma, Jinhui ^a   Sun, Wei ^a   Guo, Wanshou ^a   Li, Zirong ^a   Wang, Weiguo ^a  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Blood loss; Fibrin sealant; Meta analysis; Total knee arthroplasty; Tranexamic acid

Indexed keywords

FIBRIN GLUE; HEMOGLOBIN; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

BLEEDING; BLOOD TRANSFUSION; COCHRANE LIBRARY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; EMBASE; FEVER; HEMATOMA; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MEDLINE; META ANALYSIS; ODDS RATIO; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TOTAL KNEE ARTHROPLASTY; TRANSFUSION; WEB OF SCIENCE; WOUND INFECTION; ADVERSE EFFECTS; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; KNEE REPLACEMENT; POSTOPERATIVE HEMORRHAGE; STATISTICS AND NUMERICAL DATA; TOPICAL DRUG ADMINISTRATION; VENOUS THROMBOSIS;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, TOPICAL; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD TRANSFUSION; FEMALE; FIBRIN TISSUE ADHESIVE; HEMOGLOBINS; HUMANS; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; TRANEXAMIC ACID; VENOUS THROMBOSIS;

EID: 84976382061     PISSN: 17439191     EISSN: 17439159     Source Type: Journal    
DOI: 10.1016/j.ijsu.2016.06.009     Document Type: Review

References (28)

1. [1] Bong, M.R., Patel, V., Chang, E., et al. Risks associated with blood transfusion after total knee arthroplasty. J. Arthroplast. 19 (2004), 281–287.
2. [2] Tenholder, M., Cushner, F.D., Intraoperative blood management in joint replacement surgery. Orthopedics, 27, 2004, s663.
3. [3] Lemaire, R., Strategies for blood management in orthopaedic and trauma surgery. J. Bone Jt. Surg. Br. 90 (2008), 1128–1136.
4. [4] Tobias, J., Strategies for minimizing blood loss in orthopedic surgery. Semin. Hematol. 41 (2004), 145–156.
5. [5] Klein, H.G., Allogeneic transfusion risks in the surgical patient. Am. J. Surg. 170:6A suppl (1995), 21S–26S.
6. [6] Varney, S.J., Guest, J.F., The annual cost of blood transfusions in the UK. Transfus. Med. 13 (2003), 205–218.
7. [7] Wang, H., Shan, L., Zeng, H., et al. Is fibrin sealant effective and safe in total knee arthroplasty? A meta-analysis of randomized trials. J. Orthop. Surg. Res. 9 (2014), 1–8.
8. [8] Li, Z., Fu, X., Tian, P., et al. Fibrin sealant before wound closure in total knee arthroplasty reduced blood loss: a meta-analysis. Knee Surg. Sports Traumatol. Arthrosc. 23 (2015), 2019–2025.
9. [9] Liu, J., Cao, J., Wang, L., et al. Effect of fibrin sealant on blood loss following total knee arthroplasty: a systematic review and meta-analysis. Int. J. Surg. 12 (2014), 95–102.
10. [10] Ho, K.M., Ismail, H., Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty: a meta-analysis. Anaesth. Intensive Care 31 (2003), 529–537.
11. [11] Shemshaki, H., Nourian, S.M.A., Nourian, N., et al. One step closer to sparing total blood loss and transfusion rate in total knee arthroplasty: a meta-analysis of different methods of tranexamic acid administration. Arch. Orthop. Trauma Surg. 135 (2015), 573–588.
12. [12] Wu, Q., Zhang, H.A., Liu, S.L., et al. Is tranexamic acid clinically effective and safe to prevent blood loss in total knee arthroplasty? A meta-analysis of 34 randomized controlled trials. Eur. J. Orthop. Surg. Traumatol. 25 (2015), 525–541.
13. [13] Sierra, D.H., Fibrin sealant adhesive systems: a review of their chemistry, material properties and clinical applications. J. Biomater. Appl. 7 (1993), 309–352.
14. [14] McConnell, J.S., Shewale, S., Munro, N.A., et al. Reduction of blood loss in primary hip arthroplasty with tranexamic acid or fibrin spray: a randomized controlled trial. Acta Orthop. 82 (2011), 660–663.
15. [15] Molloy, D.O., Archbold, H.A., Ogonda, L., et al. Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement: a prospective, randomised controlled trial. J. Bone Jt. Surg. Br. 89 (2007), 306–309.
16. [16] McConnell, J.S., Shewale, S., Munro, N.A., et al. Reducing blood loss in primary knee arthroplasty: a prospective randomised controlled trial of tranexamic acid and fibrin spray. Knee 19 (2012), 295–298.
17. [17] Benoni, G., Fredin, H., Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, doubleblind study of 86 patients. J. Bone Jt. Surg. Br. 78 (1996), 434–440.
18. [18] Aguilera-Roig, X., Jordán-Sales, M., Natera-Cisneros, L., et al. Tranexamic acid in orthopedic surgery. Rev. Esp. Cir. Ortop. Traumatol. 58 (2014), 52–56.
19. [19] Sabatini, L., Atzori, F., Revello, S., et al. Intravenous use of tranexamic acid reduces postoperative blood loss in total knee arthroplasty. Arch. Orthop. Trauma Surg. 134 (2014), 1609–1614.
20. [20] Xu, Q., Yang, Y., Shi, P., et al. Repeated doses of intravenous tranexamic acid are effective and safe at reducing perioperative blood loss in total knee arthroplasty. Biosci. Trends 8 (2014), 169–175.
21. [21] Moher, D., Liberati, A., Tetzlaff, J., et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J. Clin. Epidemiol., 10, 2009, 1006.
22. [22] Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane collaboration; 2011 [ http://www.cochrane-handbook.org].
23. [23] Jadad, A.R., Moore, R.A., Carroll, D., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin. Trials 17 (1996), 1–12.
24. [24] Wells GA, O'Connell SB, Peterson D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, http://www.ohri.ca/Programs/clinical epidemiology/oxford.asp; (accessed 13. 01. 27).
25. [25] Aguilera, X., Martinez-Zapata, M.J., Bosch, A., et al. Efficacy and safety of fibrin glue and tranexamic acid to prevent postoperative blood loss in total knee arthroplasty: a randomized controlled clinical trial. J. Bone Jt. Surg. Am. 95 (2013), 2001–2007.
26. [26] Blackwell Science Ltd, Guidelines for the clinical use of red cell transfusions. Br. J. Haematol. 93 (2000), 242–255.
27. [27] Kluba, T., Fiedler, K., Kunze, B., et al. Fibrin sealants in orthopaedic surgery: practical experiences derived from use of QUIXIL® in total knee arthroplasty. Arch. Orthop. Trauma Surg. 132 (2012), 1147–1152.
28. [28] Sabatini, L., Atzori, F., Topical intra-articular and intravenous tranexamic acid to reduce blood loss in total knee arthroplasty. Ann. Transl. Med., 3((Suppl 1), 2015, S18.